ArticleBMC geriatrics2026
Prognostic utility of sarcopenia and frailty on postoperative complication and mortality in older intermediate risk cancer surgery.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research Trends in Frailty and Delirium in Older Adults: A Bibliometric Analysis.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundConditions such as sarcopenia and frailty, which become more prevalent with age, significantly influence the outcomes of older patients with cancer undergoing surgery. The aim of this study was to identify the combined effects of sarcopenia and frailty in predicting postoperative complications and mortality.
methodsThis retrospective cohort study was conducted at a university hospital from May 2019 to December 2020 and included patients aged ≥ 65 years undergoing intermediate-risk cancer surgery. Sarcopenia was defined according to the Asia Working Group for Sarcopenia 2019 guideline, and frailty was assessed using the Multidimensional Frailty Score (> 5) from comprehensive geriatric assessments. The primary outcome measured was composite postoperative complications, with secondary outcomes including one-year mortality, overall mortality, and total hospital stay.
resultsWe included 553 patients (mean age: 75.6 years). Patients with both conditions (21.1%) or frailty alone (19.3%) experienced significantly higher rates of postoperative complications and mortality than those in the normal group (9.2%) and those with only sarcopenia (14.6%). Multivariate analysis confirmed that frailty alone or both sarcopenia and frailty were independent predictors of adverse postoperative outcomes and increased mortality. Kaplan–Meier survival curves further highlighted the significant impact of the frailty-only and combined sarcopenia-frailty groups on survival.
conclusionFrailty was a strong independent predictor of adverse postoperative outcomes and mortality in older people undergoing intermediate-risk cancer surgery. Sarcopenia alone did not significantly increase this risk, and its coexistence with frailty did not independently amplify the risk beyond frailty itself. Evaluating frailty through comprehensive geriatric assessment might have helped improve surgical risk stratification and perioperative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.